Cargando…
Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars
A bibliometric analysis provided by Hernandez-Vasquez et al. listed the institutions that have published most extensively in the field of biosimilars. Sandoz and Novartis International were considered as separate entities, but are both are divisions of the same parent company. When considered as a s...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047116/ https://www.ncbi.nlm.nih.gov/pubmed/30026953 http://dx.doi.org/10.1186/s40545-018-0144-z |
_version_ | 1783339900282601472 |
---|---|
author | Cohen, Hillel P. |
author_facet | Cohen, Hillel P. |
author_sort | Cohen, Hillel P. |
collection | PubMed |
description | A bibliometric analysis provided by Hernandez-Vasquez et al. listed the institutions that have published most extensively in the field of biosimilars. Sandoz and Novartis International were considered as separate entities, but are both are divisions of the same parent company. When considered as a single entity for purposes of tracking publications, Sandoz-Novartis is among the leaders in the number of articles published about biosimilars. |
format | Online Article Text |
id | pubmed-6047116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60471162018-07-19 Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars Cohen, Hillel P. J Pharm Policy Pract Letter to the Editor A bibliometric analysis provided by Hernandez-Vasquez et al. listed the institutions that have published most extensively in the field of biosimilars. Sandoz and Novartis International were considered as separate entities, but are both are divisions of the same parent company. When considered as a single entity for purposes of tracking publications, Sandoz-Novartis is among the leaders in the number of articles published about biosimilars. BioMed Central 2018-07-16 /pmc/articles/PMC6047116/ /pubmed/30026953 http://dx.doi.org/10.1186/s40545-018-0144-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Cohen, Hillel P. Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars |
title | Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars |
title_full | Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars |
title_fullStr | Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars |
title_full_unstemmed | Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars |
title_short | Comment on Hernandez-Vasquez et al., a bibliometric analysis of the global research on biosimilars |
title_sort | comment on hernandez-vasquez et al., a bibliometric analysis of the global research on biosimilars |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047116/ https://www.ncbi.nlm.nih.gov/pubmed/30026953 http://dx.doi.org/10.1186/s40545-018-0144-z |
work_keys_str_mv | AT cohenhillelp commentonhernandezvasquezetalabibliometricanalysisoftheglobalresearchonbiosimilars |